Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
MET

MET - MetLife Inc Stock Price, Fair Value and News

74.23USD+0.76 (+1.03%)Market Closed

Market Summary

MET
USD74.23+0.76
Market Closed
1.03%

MET Alerts

  • Big jump in Earnings (Y/Y)

MET Stock Price

View Fullscreen

MET RSI Chart

MET Valuation

Market Cap

52.8B

Price/Earnings (Trailing)

22.32

Price/Sales (Trailing)

0.78

EV/EBITDA

8.26

Price/Free Cashflow

3.76

MET Price/Sales (Trailing)

MET Profitability

EBT Margin

4.37%

Return on Equity

8.21%

Return on Assets

0.35%

Free Cashflow Yield

26.57%

MET Fundamentals

MET Revenue

Revenue (TTM)

67.6B

Rev. Growth (Yr)

4.35%

Rev. Growth (Qtr)

-15.61%

MET Earnings

Earnings (TTM)

2.4B

Earnings Growth (Yr)

983.75%

Earnings Growth (Qtr)

42.83%

Breaking Down MET Revenue

Last 7 days

2.1%

Last 30 days

7.7%

Last 90 days

7.9%

Trailing 12 Months

43.1%

How does MET drawdown profile look like?

MET Financial Health

Debt/Equity

0.66

Debt/Cashflow

0.74

MET Investor Care

Dividend Yield

2.8%

Dividend/Share (TTM)

2.08

Buy Backs (1Y)

7.14%

Diluted EPS (TTM)

2.91

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202467.6B000
202368.8B69.9B63.5B66.9B
202268.5B65.5B70.9B68.8B
202165.1B69.5B70.4B68.7B
202071.6B68.2B65.6B67.8B
201969.4B65.8B68.1B69.6B
201862.1B68.0B68.1B67.9B
201759.5B58.8B59.1B62.3B
201661.2B63.0B62.9B60.6B
201572.5B68.4B65.5B61.3B
201467.6B70.1B72.7B73.3B
201369.9B67.2B67.1B68.2B
201270.3B71.5B67.6B68.2B
201155.1B58.1B66.2B70.2B
201043.9B49.8B51.9B52.2B
200949.6B45.8B42.7B41.1B
2008048.4B49.7B51.0B
200700047.2B
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index

Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022


Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.

S&P 500 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of MetLife Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 01, 2024
hay laura j
acquired
43,771
73.69
594
-
Apr 01, 2024
kinney catherine r
acquired
-
-
594
-
Apr 01, 2024
johnson jeh c.
acquired
43,771
73.69
594
-
Apr 01, 2024
herzog david l
acquired
-
-
594
-
Apr 01, 2024
hubbard robert glenn
acquired
75,016
73.69
1,018
-
Apr 01, 2024
grise cheryl w
acquired
43,771
73.69
594
-
Apr 01, 2024
kelly edward j iii
acquired
43,771
73.69
594
-
Apr 01, 2024
hassell gerald l
acquired
43,771
73.69
594
-
Apr 01, 2024
mckenzie diana
acquired
43,771
73.69
594
-
Apr 01, 2024
harris carla a
acquired
43,771
73.69
594
-

1–10 of 50

Which funds bought or sold MET recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
May 17, 2024
Aspect Partners, LLC
unchanged
-
806
7,485
0.01%
May 17, 2024
Plato Investment Management Ltd
added
921
1,203,220
1,318,420
0.14%
May 17, 2024
Kozak & Associates, Inc.
added
3.53
2,865
28,001
0.01%
May 17, 2024
New Covenant Trust Company, N.A.
new
-
18,898
18,898
0.02%
May 16, 2024
B. Riley Wealth Advisors, Inc.
added
7.35
23,461
1,129,980
0.03%
May 16, 2024
Beacon Capital Management, LLC
added
3.2
8,482
47,801
0.01%
May 16, 2024
Meiji Yasuda Life Insurance Co
new
-
595,770
595,770
0.01%
May 16, 2024
Pineridge Advisors LLC
reduced
-4.54
2,747
42,094
0.01%
May 16, 2024
COMERICA BANK
reduced
-5.9
837,449
16,191,300
0.07%
May 16, 2024
Global Financial Private Client, LLC
unchanged
-
6,865
66,911
0.03%

1–10 of 44

Are Funds Buying or Selling MET?

Are funds buying MET calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MET
No. of Funds

Unveiling MetLife Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
May 02, 2024
board of directors of metlife inc
16.2%
115,248,427
SC 13D/A
Feb 15, 2024
board of directors of metlife inc
16.2%
116,905,555
SC 13D/A
Feb 13, 2024
dodge & cox
7.2%
53,443,191
SC 13G/A
Feb 13, 2024
vanguard group inc
7.79%
57,648,051
SC 13G/A
Jan 26, 2024
blackrock inc.
7.1%
52,733,080
SC 13G/A
Nov 02, 2023
board of directors of metlife inc
16.0%
118,254,445
SC 13D/A
Aug 04, 2023
board of directors of metlife inc
16.0%
120,043,226
SC 13D/A
May 04, 2023
board of directors of metlife inc
15.9%
121,521,424
SC 13D/A
Feb 23, 2023
board of directors of metlife inc
15.9%
122,923,807
SC 13D/A
Feb 14, 2023
dodge & cox
6.8%
53,583,210
SC 13G/A

Recent SEC filings of MetLife Inc

View All Filings
Date Filed Form Type Document
May 15, 2024
8-K
Current Report
May 14, 2024
13F-HR
Fund Holdings Report
May 08, 2024
PX14A6G
PX14A6G
May 02, 2024
10-Q
Quarterly Report
May 02, 2024
SC 13D/A
13D - Major Acquisition
May 01, 2024
8-K
Current Report
Apr 26, 2024
ARS
ARS
Apr 26, 2024
DEF 14A
DEF 14A
Apr 26, 2024
DEFA14A
DEFA14A
Apr 03, 2024
4
Insider Trading

Peers (Alternatives to MetLife Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
1.1T
1.3B
1.56% 3220.84%
-5.4K
851.43
-10.27% -34.69%
56.3B
10.6B
11.80% 20.14%
51.57
5.3
20.42% -6.05%
53.5B
48.4B
11.01% 48.35%
11.07
1.1
-4.15% -20.63%
50.3B
42.9B
6.36% 19.84%
16.03
1.17
13.52% 12.15%
50.2B
19.3B
10.10% 32.07%
9.39
2.6
3.03% 17.35%
37.9B
14.4B
11.43% 34.12%
7.82
2.63
32.92% 143.01%
11.2B
8.0B
7.21% 13.44%
12.7
1.4
11.14% 7.56%
MID-CAP
10.1B
12.6B
5.84% 14.37%
7.61
0.8
4.24% -13.40%
9.1B
11.4B
3.23% 33.23%
11.93
0.8
9.81% 217.29%
5.1B
11.9B
12.70% 41.34%
3.81
0.43
-33.27% 234.43%
3.9B
3.2B
-0.20% 45.14%
5.55
1.23
64.05% -35.60%
SMALL-CAP
2.0B
1.3B
23.61% 49.66%
-37.13
1.59
18.74% 30.90%
887.3M
308.9M
-4.69% -15.41%
14.38
2.87
3.79% 10.94%
818.6M
314.0M
28.73% 23.89%
14.24
2.61
-29.20% -88.19%
35.5M
187.5M
-11.22% -20.55%
-49.09
0.19
2.74% 73.83%

MetLife Inc News

Latest updates
MarketBeat12 hours ago
MarketWatch16 May 202408:51 pm
Yahoo News UK16 May 202408:48 am
MarketWatch15 May 202408:51 pm
Business Wire15 May 202408:15 pm
MarketWatch14 May 202408:51 pm
Yahoo Movies UK14 May 202402:54 pm

MetLife Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-15.6%16,05719,02815,86616,62315,38815,60822,28315,47415,40517,70516,90518,52415,56219,41816,01514,09918,31017,14318,67817,49716,302
Operating Expenses-3.0%3,2173,3163,2043,1333,0574.002,9222,9082,95210.003,2842,8813,1503,4243,4702,9833,2733,6313,4433,3903,225
EBITDA Margin25.3%0.06*0.05*0.07*0.07*0.08*0.11*0.10*0.12*0.16*0.14*0.11*0.10*---------
Interest Expenses-25.7%231311206289183314156285150308166287153312153290136317137362148
Income Taxes-48.0%17032739.0022.00172-67.0024873.00296-34.004531,075-72.006.0021447.001,242-625601551359
Earnings Before Taxes11.1%1,0459415344302572,0261,4159881,9351,6982,0424,4872911649231975,643-37.002,7912,2971,744
EBT Margin35.1%0.04*0.03*0.05*0.06*0.07*0.09*0.09*0.10*0.15*0.12*0.10*0.08*---------
Net Income42.8%86760748940280.001,5781,1629101,6341,5041,5843,4073631587061454,4015932,1841,7411,381
Net Income Margin48.4%0.03*0.02*0.04*0.05*0.05*0.08*0.07*0.09*0.12*0.10*0.08*0.07*---------
Free Cashflow-55.1%2,3285,1823,4753,0382,0262,3014,3104,3932,0405,0913,5062,254---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-1.5%677,576687,584652,120677,279674,266663,072650,104662,893724,284759,708761,664773,253769,814795,146780,492767,583737,741740,463742,812732,167713,188
    Cash Equivalents-3.9%19,84020,63914,91215,41718,45620,19522,20020,54823,48820,04718,95625,03719,63519,79524,40524,28924,09416,59819,45218,43514,506
  Goodwill-2.2%9,0379,2369,1099,2619,3799,2979,0059,1519,5109,5359,6389,7689,94410,1129,3609,2459,1599,3089,2789,4089,418
Liabilities-1.3%648,780657,331626,225646,787641,843632,947624,774625,526670,047691,959692,331703,830703,677720,329706,923691,643667,278674,081674,193668,121654,450
  Short Term Borrowings6.7%127119161200168175183196323341346393302393351303298235142158289
Shareholder's Equity-4.1%28,79630,01525,65830,49232,42329,88129,64034,00942,70350,01369,33369,42366,13774,81773,56975,94070,46366,38268,61964,04658,738
  Retained Earnings0.5%40,35040,14639,95839,92839,95740,33241,03241,10141,40641,19740,42639,31836,37331,82436,78236,56836,91933,07832,94831,20929,944
  Additional Paid-In Capital0.1%33,71833,69033,66633,63033,61733,61633,58933,54833,53133,51133,45733,44033,91033,81233,74433,72833,71132,68032,63932,60232,535
Shares Outstanding-2.1%716731744757769779787798815826845861---------
Minority Interest9.7%261238237231229244254266272267283285273259253247242238251235229
Float----42,800---50,100---51,500---33,100---46,500-
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-55.1%2,3285,1823,4753,0382,0262,3014,3104,3932,0405,0913,5062,2541,4965,1533,7938461,8475,1814,1462,3872,072
Cashflow From Investing-556.1%-2,627576-2,972-6,346-1,504-197-4,1122,115-426-2,862-8,2801,009-1,054-2,162-6,679-1,391-8,337-7,093-5,351557-5,699
Cashflow From Financing-48.3%-261-176-848379-2,295-4,4681,743-9,0881,865-1,086-1,1081,632-564-6,9932,88568014,157-1,0092,3279342,316
  Dividend Payments-2.3%377386392399389393400408397405413421408415419419404406413419405
  Buy Backs36.4%1,1728597926727805966741,1169401,1761,0151,11399957180.00-500250785750500
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

MET Income Statement

2024-03-31
Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues  
Premiums$ 10,053$ 9,589
Universal life and investment-type product policy fees1,2481,289
Net investment income5,4364,645
Other revenues674639
Net investment gains (losses)(375)(684)
Net derivative gains (losses)(979)(90)
Total revenues16,05715,388
Expenses  
Policyholder benefits and claims10,0749,872
Policyholder liability remeasurement (gains) losses(22)(9)
Market risk benefit remeasurement (gains) losses(694)188
Interest credited to policyholder account balances2,2901,864
Policyholder dividends147159
Other expenses3,2173,057
Total expenses15,01215,131
Income (loss) before provision for income tax1,045257
Provision for income tax expense (benefit)170172
Net income (loss)87585
Less: Net income (loss) attributable to noncontrolling interests85
Net income (loss) attributable to MetLife, Inc.86780
Dividends, Preferred Stock6766
Net income (loss) available to MetLife, Inc.’s common shareholders80014
Comprehensive income (loss)3473,541
Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax9(13)
Comprehensive income (loss) attributable to MetLife, Inc.$ 338$ 3,554
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:  
Basic$ 1.11$ 0.02
Diluted$ 1.10$ 0.02

MET Balance Sheet

2024-03-31
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Investments:  
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $113 and $184, respectively); and amortized cost: $300,623 and $300,555, respectively$ 278,409$ 281,412
Equity securities750757
Contractholder-directed equity securities and fair value option securities, at estimated fair value10,31310,331
Mortgage loans (net of allowance for credit loss of $814 and $721, respectively)91,45892,506
Policy loans8,8008,788
Real estate and real estate joint ventures (includes $328 and $317, respectively, under the fair value option)12,99213,332
Other limited partnership interests14,30114,764
Short-term investments, principally at estimated fair value4,8846,045
Other invested assets (includes $1,843 and $1,993, respectively, of leveraged and direct financing leases; $432 and $333, respectively, relating to variable interest entities)18,09718,202
Total investments440,004446,137
Cash and cash equivalents, principally at estimated fair value19,84020,639
Accrued investment income3,6363,589
Premiums, reinsurance and other receivables29,98628,971
Market risk benefits351286
Deferred policy acquisition costs and value of business acquired19,84220,151
Current income tax recoverable0190
Deferred income tax asset2,7512,612
Goodwill9,0379,236
Other assets11,12611,139
Separate account assets141,003144,634
Total assets677,576687,584
Liabilities  
Future policy benefits191,013196,406
Policyholder account balances219,168219,269
Market risk benefits2,6963,179
Other policy-related balances20,21919,736
Policyholder dividends payable357386
Payables for collateral under securities loaned and other transactions17,47017,524
Short-term debt127119
Long-term debt (includes $26 and $0, respectively, relating to variable interest entities)15,97215,548
Collateral financing arrangement590637
Junior subordinated debt securities3,1623,161
Current income tax payable100
Deferred income tax liability835927
Other liabilities36,15835,805
Separate account liabilities141,003144,634
Total liabilities648,780657,331
Contingencies, Commitments and Guarantees (Note 19)
MetLife, Inc.’s stockholders’ equity:  
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference00
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,193,562,132 and 1,191,823,651 shares issued, respectively; 715,661,353 and 730,821,111 shares outstanding, respectively1212
Additional paid-in capital33,71833,690
Retained earnings40,35040,146
Treasury stock, at cost; 477,900,779 and 461,002,540 shares, respectively(25,774)(24,591)
Accumulated other comprehensive income (loss)(19,771)(19,242)
Total MetLife, Inc.’s stockholders’ equity28,53530,015
Noncontrolling interests261238
Total equity28,79630,253
Total liabilities and equity$ 677,576$ 687,584
MET
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
 CEO
 WEBSITEmetlife.com
 INDUSTRYInsurance Property & Casualty
 EMPLOYEES45000

MetLife Inc Frequently Asked Questions


What is the ticker symbol for MetLife Inc? What does MET stand for in stocks?

MET is the stock ticker symbol of MetLife Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MetLife Inc (MET)?

As of Fri May 17 2024, market cap of MetLife Inc is 52.79 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MET stock?

You can check MET's fair value in chart for subscribers.

What is the fair value of MET stock?

You can check MET's fair value in chart for subscribers. The fair value of MetLife Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MetLife Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MET so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MetLife Inc a good stock to buy?

The fair value guage provides a quick view whether MET is over valued or under valued. Whether MetLife Inc is cheap or expensive depends on the assumptions which impact MetLife Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MET.

What is MetLife Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, MET's PE ratio (Price to Earnings) is 22.32 and Price to Sales (PS) ratio is 0.78. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MET PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MetLife Inc's stock?

In the past 10 years, MetLife Inc has provided 0.084 (multiply by 100 for percentage) rate of return.